Optic Neuropathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
The Optic Neuropathy pipeline market research report provides an overview of the Optic Neuropathy pipeline landscape. The report provides comprehensive information on the therapeutics under development for Optic Neuropathy, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Optic Neuropathy and features dormant and discontinued projects.
Optic Neuropathy Pipeline Drugs Market by Key Targets
The targets of the Optic Neuropathy pipeline drugs market are BDNF/NT 3 Growth Factors Receptor, Caspase 2, Erythropoietin Receptor, Gap Junction Alpha 1 Protein, Placenta Growth Factor, Semaphorin 3A, and Vascular Endothelial Growth Factor A .
Optic Neuropathy Pipeline Drugs Market, by Targets
For more target insights, download a free report sample
Key Mechanisms of Action in the Optic Neuropathy Pipeline Drugs Market
The mechanisms of action of the Optic Neuropathy pipeline drugs market are BDNF/NT 3 Growth Factors Receptor Agonist, Caspase 2 Inhibitor, Erythropoietin Receptor Agonist, Gap Junction Alpha 1 Protein Inhibitor, Placenta Growth Factor Inhibitor, Semaphorin 3A Inhibitor, and Vascular Endothelial Growth Factor A Inhibitor.
Optic Neuropathy Pipeline Drugs Market, by Mechanisms of Action
For more mechanisms of action insights, download a free report sample
Key Routes of Administration in the Optic Neuropathy Pipeline Drugs Market
The routes of administration in the Optic Neuropathy pipeline drugs market are intravitreal, parenteral, subconjunctival, subcutaneous, and topical.
Optic Neuropathy Pipeline Drugs Market, by Routes of Administration
For more routes of administration insights, download a free report sample
Key Molecule Types in the Optic Neuropathy Pipeline Drugs Market
The molecule types in the Optic Neuropathy pipeline drugs market are small molecule, cell therapy, antisense RNAi oligonucleotide, fusion protein, monoclonal antibody, protein, and synthetic peptide.
Optic Neuropathy Pipeline Drugs Market, by Molecule Types
For more molecule type insights, download a free report sample
Key Optic Neuropathy Pipeline Drugs Market Companies
Some of the key companies in the Optic Neuropathy pipeline drugs market are Neurizon Pharma GBR, Astellas Pharma Inc, Biozeus Pharmaceutical SA, jCyte Inc, PharmatrophiX Inc, Quark Pharmaceuticals Inc, and Regeneron Pharmaceuticals Inc. Neurizon Pharma GBR has the highest number of pipeline products.
Optic Neuropathy Pipeline Drugs Market, by Key Companies
To know more about key companies, download a free report sample
Market Report Overview
Key Targets | BDNF/NT 3 Growth Factors Receptor, Caspase 2, Erythropoietin Receptor, Gap Junction Alpha 1 Protein, Placenta Growth Factor, Semaphorin 3A, and Vascular Endothelial Growth Factor A |
Key Mechanisms of Action | BDNF/NT 3 Growth Factors Receptor Agonist, Caspase 2 Inhibitor, Erythropoietin Receptor Agonist, Gap Junction Alpha 1 Protein Inhibitor, Placenta Growth Factor Inhibitor, Semaphorin 3A Inhibitor, and Vascular Endothelial Growth Factor A Inhibitor |
Key Routes of Administration | Intravitreal, Parenteral, Subconjunctival, Subcutaneous, and Topical |
Key Molecule Types | Small Molecule, Cell Therapy, Antisense RNAi Oligonucleotide, Fusion Protein, Monoclonal Antibody, Protein, and Synthetic Peptide |
Key Companies | Neurizon Pharma GBR, Astellas Pharma Inc, Biozeus Pharmaceutical SA, jCyte Inc, PharmatrophiX Inc, Quark Pharmaceuticals Inc, and Regeneron Pharmaceuticals Inc |
Scope
This report provides:
- A snapshot of the global therapeutic landscape of Optic Neuropathy (Ophthalmology).
- Reviews of pipeline therapeutics for Optic Neuropathy (Ophthalmology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Pipeline products based on several stages of development ranging from pre-registration to discovery and undisclosed stages.
- Descriptive drug profiles for the pipeline products which include product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities.
- Reviews of key companies involved in Optic Neuropathy (Ophthalmology) therapeutics and enlists all their major and minor projects.
- Evaluation of Optic Neuropathy (Ophthalmology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- All the dormant and discontinued pipeline projects.
- Reviews of the latest news and deals related to pipeline therapeutics for Optic Neuropathy (Ophthalmology).
Reasons to Buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Optic Neuropathy (Ophthalmology).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Optic Neuropathy (Ophthalmology) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Biozeus Pharmaceutical SA
jCyte Inc
Neurizon Pharma GBR
PharmatrophiX Inc
Quark Pharmaceuticals Inc
Regeneron Pharmaceuticals Inc
Table of Contents
Table
Figures
Frequently asked questions
-
What are the key targets of the Optic Neuropathy pipeline drugs market?
Some of the targets of the Optic Neuropathy pipeline drugs market are BDNF/NT 3 Growth Factors Receptor, Caspase 2, Erythropoietin Receptor, Gap Junction Alpha 1 Protein, Placenta Growth Factor, Semaphorin 3A, and Vascular Endothelial Growth Factor A.
-
What are the key mechanisms of action of the Optic Neuropathy pipeline drugs market?
Some of the key mechanisms of action of the Optic Neuropathy pipeline drugs market are BDNF/NT 3 Growth Factors Receptor Agonist, Caspase 2 Inhibitor, Erythropoietin Receptor Agonist, Gap Junction Alpha 1 Protein Inhibitor, Placenta Growth Factor Inhibitor, Semaphorin 3A Inhibitor, and Vascular Endothelial Growth Factor A Inhibitor.
-
What are the routes of administration in the Optic Neuropathy pipeline drugs market?
The routes of administration in the Optic Neuropathy pipeline drugs market are intravitreal, parenteral, subconjunctival, subcutaneous, and topical.
-
What are the molecule types in the Optic Neuropathy pipeline drugs market?
The molecule types in the Optic Neuropathy pipeline drugs market are small molecule, cell therapy, antisense RNAi oligonucleotide, fusion protein, monoclonal antibody, protein, and synthetic peptide.
-
Which are the key companies in the Optic Neuropathy pipeline drugs market?
Some of the key companies in the Optic Neuropathy pipeline drugs market are Neurizon Pharma GBR, Astellas Pharma Inc, Biozeus Pharmaceutical SA, jCyte Inc, PharmatrophiX Inc, Quark Pharmaceuticals Inc, and Regeneron Pharmaceuticals Inc.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.